Isolation of a Highly Myogenic CD34-Negative Subset of Human Skeletal Muscle Cells Free of Adipogenic Potential

Stem Cells

Volumn 28, Issue 4, 2010, Pages 753-764

  Pisani, Didier F ^a   Dechesne, Claude A ^a   Sacconi, Sabrina ^a,b   Delplace, Severine ^b   Belmonte, Nathalie ^b   Cochet, Olivia ^a   Clement, Noémie ^a,b   Wdziekonski, Brigitte ^a   Villageois, Albert P ^a   Butori, Catherine ^f   Bagnis, Claude ^c   Di Santo, James P ^d   Kurzenne, Jean Yves ^e   Desnuelle, Claude ^a,b   Dani, Christian ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b UNIVERSITY HOSPITAL OF NICE   (France)

^c ETABLISSEMENT FRANÇAIS DU SANG   (France)

^d INSTITUT PASTEUR   (France)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^f PASTEUR HOSPITAL   (France)

Author keywords

Adipocyte; CD56; Cell therapy; Dystrophy; Myoblast

Indexed keywords

CD34 ANTIGEN;

ADIPOCYTE; ADIPOGENESIS; ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CD34 SELECTION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL SUBPOPULATION; CELL TRANSPLANTATION; CHILD; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; MALE; MOUSE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE REGENERATION; NONHUMAN; PHENOTYPE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE CELL;

ADIPOCYTES; ADOLESCENT; ADULT; ANIMALS; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFANT; MALE; MICE; MUSCLE FIBERS, SKELETAL;

EID: 77951016345     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.317     Document Type: Article

References (41)

1. Goodpaster BH, Wolf D. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatr Diabetes 2004;5(4):219-226. (Pubitemid 40057693)
2. Delmonico MJ, Harris TB, Visser M et al. Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr 2009;90(6):1579-1585.
3. Emery AE. The muscular dystrophies. Lancet 2002;359(9307):687-695.
4. McNally EM, Pytel P. Muscle diseases: The muscular dystrophies. Annu Rev Pathol 2007;2:87-109.
5. Ozsarlak O, Schepens E, Parizel PM et al. Hereditary neuromuscular diseases. Eur J Radiol 2001;40(3):184-197.
6. Wren TA, Bluml S, Tseng-Ong L et al. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. AJR Am J Roentgenol 2008;190(1):W8-12.
7. Péault B, Rudnicki M, Torrente Y et al. Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther 2007;15(5):867-877. (Pubitemid 46621645)
8. Skuk D, Tremblay JP. Myoblast transplantation: The current status of a potential therapeutic tool for myopathies. J Muscle Res Cell Motil 2003;24(4-6):285-300. (Pubitemid 37323636)
9. Partridge T. Myoblast transplantation. Neuromuscul Disord 2002;12 Suppl 1:S3-6.
10. Skuk D, Goulet M, Roy B et al. Dystrophin expression in muscles of duchenne muscular dystrophy patients after high-density injections of normal myogenic cells. J Neuropathol Exp Neurol 2006;65(4):371-386. (Pubitemid 44264834)
11. Skuk D, Goulet M, Roy B et al. First test of a "high-density injection" protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: Eighteen months follow-up. Neuromuscul Disord 2007;17(1):38-46.
12. Vilquin JT, Marolleau JP, Sacconi S et al. Normal growth and regenerating ability of myoblasts from unaffected muscles of facioscapulohumeral muscular dystrophy patients. Gene Ther 2005;12(22):1651-1662. (Pubitemid 41670355)
13. Belles-Isles M, Roy R, Dansereau G et al. Rapid selection of donor myoblast clones for muscular dystrophy therapy using cell surface expression of NCAM. Eur J Histochem 1993;37(4):375-380. (Pubitemid 2027227)
14. Capkovic KL, Stevenson S, Johnson MC et al. Neural cell adhesion molecule (NCAM) marks adult myogenic cells committed to differentiation. Exp Cell Res 2008;314(7):1553-1565.
15. Sinanan AC, Hunt NP, Lewis MP. Human adult craniofacial musclederived cells: neural-cell adhesion-molecule (NCAM; CD56)-expressing cells appear to contain multipotential stem cells. Biotechnol Appl Biochem 2004;40(Pt 1):25-34.
16. Schofield R. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 1978;4(1-2):7-25. (Pubitemid 8376317)
17. Montgomery M, Cottler-Fox M. Mobilization and collection of autologous hematopoietic progenitor/stem cells. Clin Adv Hematol Oncol 2007;5(2):127-136. (Pubitemid 46455272)
18. Jankowski RJ, Deasy BM, Cao B et al. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J Cell Sci 2002;115(Pt 22):4361-4374. (Pubitemid 35460706)
19. Jankowski RJ, Huard J. Myogenic cellular transplantation and regeneration: Sorting through progenitor heterogeneity. Panminerva Med 2004;46(1):81-91. (Pubitemid 39090622)
20. Rouas R, Uch R, Cleuter Y et al. Lentiviral-mediated gene delivery in human monocyte-derived dendritic cells: Optimized design and procedures for highly efficient transduction compatible with clinical constraints. Cancer Gene Ther 2002;9(9):715-724. (Pubitemid 34971302)
21. Goudenege S, Pisani DF, Wdziekonski B et al. Enhancement of myogenic and muscle repair capacities of human adipose-derived stem cells with forced expression of MyoD. Mol Ther 2009;17(6):1064-1072.
22. Cooper RN, Irintchev A, Di Santo JP et al. A new immunodeficient mouse model for human myoblast transplantation. Hum Gene Ther 2001;12(7):823-831. (Pubitemid 32692347)
23. Yoshimura K, Shigeura T, Matsumoto D et al. Characterization of freshly isolated and cultured cells derived from the fatty and fluid portions of liposuction aspirates. J Cell Physiol 2006;208(1):64-76. (Pubitemid 43848990)
24. Bouchentouf M, Benabdallah BF, Tremblay JP. Myoblast survival enhancement and transplantation success improvement by heat-shock treatment in mdx mice. Transplantation 2004;77(9):1349-1356. (Pubitemid 38668426)
25. Riederer I, Negroni E, Bigot A et al. Heat shock treatment increases engraftment of transplanted human myoblasts into immunodeficient mice. Transplant Proc 2008;40(2):624-630. (Pubitemid 351406419)
26. WangW, Pan H,Murray K et al.Matrixmetalloproteinase-1 promotes muscle cellmigration and differentiation. AmJ Pathol 2009;174(2):541-549.
27. Torrente Y, Belicchi M, Marchesi C et al. Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients. Cell Transplant 2007;16(6):563-577. (Pubitemid 351448271)
28. Sampaolesi M, Blot S, D'Antona G et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006;444(7119):574-579. (Pubitemid 44864430)
29. Skuk D, Paradis M, Goulet M et al. Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: Implications for cell-transplantation strategies. Transplantation 2007;84(10):1307-1315. (Pubitemid 351339319)
30. Ailhaud G. Adipose tissue as a secretory organ: From adipogenesis to the metabolic syndrome. C R Biol 2006;329(8):570-577, discussion 653-1575 (Pubitemid 44081126)
31. Praud C, Vauchez K, Lombes A et al. Myoblast xenotransplantation as a tool to evaluate the appropriateness of nanoparticular versus cellular trackers. Cell Transplant 2008;17(9):1035-1043.
32. Summan M, Warren GL, Mercer RR et al. Macrophages and skeletal muscle regeneration: A clodronate-containing liposome depletion study. Am J Physiol Regul Integr Comp Physiol 2006;290(6):R1488-1495. (Pubitemid 43830809)
33. Wagatsuma A. Upregulation of gene encoding adipogenic transcriptional factors C/EBPalpha and PPARgamma2 in denervated muscle. Exp Physiol 2006;91(4):747-753. (Pubitemid 43944646)
34. Wagatsuma A. Adipogenic potential can be activated during muscle regeneration. Mol Cell Biochem 2007;304(1-2):25-33. (Pubitemid 47456849)
35. de Castro Rodrigues A, Andreo JC, Rosa GM Jr et al. Fat cell invasion in long-term denervated skeletal muscle. Microsurgery 2007;27(8):664-667. (Pubitemid 350175153)
36. Arsic N, Zacchigna S, Zentilin L et al. Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 2004;10(5):844-854. (Pubitemid 39419911)
37. Kawai H, Nishino H, Kusaka K et al. Experimental glycerol myopathy: A histological study. Acta Neuropathol 1990;80(2):192-197. (Pubitemid 20196810)
38. Vauchez K, Marolleau JP, Schmid M et al. Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities. Mol Ther 2009.
39. Torrente Y, Belicchi M, Sampaolesi M et al. Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 2004;114(2):182-195. (Pubitemid 39071623)
40. Dreyfus PA, Chretien F, Chazaud B et al. Adult bone marrow-derived stem cells in muscle connective tissue and satellite cell niches. Am J Pathol 2004;164(3):773-779. (Pubitemid 38235459)
41. Sampaolesi M, Torrente Y, Innocenzi A et al. Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science 2003;301(5632):487-492. (Pubitemid 36900300)